Check out how Mayo Clinic Laboratories’ digital pathology initiative integrates digital infrastructure to deliver digital workflows for patients to improve overall care.
Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.
Ceramides are lipids associated with atherosclerotic plaque formation, hypertension, insulin resistance, and obesity. Mayo Clinic Laboratories’ testing quantifies ceramides, providing an early indicator to help physicians predict heart...
A Test in Focus Archives - Page 7 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
A Test in Focus Archives - Page 9 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
A Test in Focus Archives - Page 8 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
At Mayo Clinic Laboratories, familial variant analysis can clarify genetic variants in family members when a variant of interest has been previously identified.
Precision pain management - Insights
Our liquid chromatography-tandem mass spectrometry, high-resolution accurate mass (LC-MS/MS HRAM) screens, and confirmatory testing for controlled substances are available based on the needs of your patients.
Skip to Content MayoACCESS MayoLINK...
Our suite of preeclampsia, prenatal, breast and gynecological cancer, and other testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.